Navigation Links
Hospital study finds connection between dementia, delirium and declining health
Date:9/16/2013

More than half of all patients with pre-existing dementia will experience delirium while hospitalized. Failing to detect and treat their delirium early leads to a faster decline of both their physical and mental health, according to health researchers.

"This study is important, as delirium is often overlooked and minimized in the hospital setting, especially in persons with dementia," said Donna M. Fick, Distinguished Professor of Nursing at Penn State and principal investigator for this study. "And it illustrates that delirium is deadly, costly and impacts patient functioning."

The researchers followed 139 hospitalized adults, ages 65 and older, with dementia and found that the patients who developed delirium had a 25 percent chance of dying within 30 days, as reported in the current issue of the Journal of Hospital Medicine.

Dementia is an irreversible, progressive condition that affects cognitive and physical function. Symptoms usually occur over months to years and can include memory loss, inability to solve simple problems, difficulties with language and thinking, personality and behavior changes and other mental problems.

Delirium, on the other hand, is a reversible cognitive condition that comes on quickly and if caught and treated early can be resolved. Many of the symptoms of delirium may appear similar to dementia, but signs such as marked inattention and sleepiness or hyperactivity can help differentiate delirium from dementia.

Fick and colleagues focused on this combination of disorders, known as delirium superimposed on dementia (DSD), in this study. The researchers found a 32 percent incidence of new delirium in the hospitalized patients with dementia. These patients stayed in the hospital about four days longer than patients without delirium, and also had a reduced level of physical and mental ability when they left the hospital and at follow-up visits one month later. Additionally, patients with DSD were more likely to have died a month after their hospital stay.

Previous studies have found the cost of delirious episodes rivals those for diabetes and heart disease. Decreasing the length of stay by just one day would save more than $20 million in health care costs per year.

Common causes of delirium are infections, dehydration and medication changes. A third of the patients in this study arrived at the hospital dehydrated.

"Preventing delirium is important because we want to discharge patients at their baseline or improved functioning," said Fick. "We do not want them to go home with worse functioning than when they came into the hospital."

The goal of the researchers is to help practitioners recognize and treat delirium in patients with DSD as early as possible, helping to improve quality of life for the patient.


'/>"/>

Contact: Victoria M. Indivero
vmi1@psu.edu
814-865-9481
Penn State
Source:Eurekalert

Related medicine news :

1. Care Logistics Launches Order Logistics as Part of the Hospital Operating System (TM)
2. New Mobile App from The Children’s Hospital of Philadelphia Assists Parents, Doctors with Vaccine Decisions
3. Vermont Hospitals Commit to a Healthier Future with the First Statewide Enrollment in the Healthier Hospitals Initiative
4. Abt Associates to Evaluate Hospital Innovations Designed to Improve Care, Lower Costs
5. Firefly Fuel Introduces a Line of Refillable Oil Lamps, Oil Candles and Eco-Friendly Lamp Oil Supporting Hospitality Sustainability
6. Low dose antibiotic treatment of C-difficile as effective as high dose in hospital setting
7. Changing part of central line could reduce hospital infections
8. Florida Hospital and Tampa Bay Buccaneers Announce Innovative Health Partnership
9. Health Data Intelligence Delivers a Critical Patient Safety and Infection Control Surveillance Tool with the Introduction of the Hospital Complications Dashboard
10. International Essential Tremor Foundation to Facilitate Educational Seminar at Pennsylvania Hospital on the Neurological Disorder, Essential Tremor
11. Advanced Sinus Treatment Available at Kishwaukee Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... California (PRWEB) , ... January 17, 2017 , ... ... have a point of difference. Eden Activewear is a stand-out company for several ... are exclusively online and only manufacture on demand, this is called 'Agile' manufacturing ...
(Date:1/17/2017)... ... , ... Kevin Harrington (one of the original Sharks from mega-hit reality series ... topic of Beauty and Personal Care. , Everyone makes New Year’s ... commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro will ...
(Date:1/17/2017)... Lehi, Utah (PRWEB) , ... January 17, 2017 ... ... provider of accredited, online continuing education for EMS and firefighting professionals, has released ... Training (VILT) Solution. These new courses are taught live in an online classroom ...
(Date:1/17/2017)... ... ... Neil H. Greco Insurance Agency, a northern New Jersey firm that provides ... a charity drive to raise awareness of heart disease and promote habits that improve ... is responsible for 1 in every 4 deaths at the national level each year. ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... breast cancer survivor Sandra Lee as keynote speaker for the 34th Annual Miami ... , In making the announcement, PER® president, Phil Talamo, said, “We are delighted ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017 Paragon Bioservices ... provide product development services for a variety of ... (NIAID) medical product development activities. The IDIQ ... contractor pool for task order awards up to ... leader in manufacturing and process development of biopharmaceuticals, ...
(Date:1/17/2017)... -- Management to Discuss Acquisition of ... KIT-302 Development On Track For An NDA Submission ... Q1 2017   ... Ltd. (NASDAQ: KTOV ; TASE: KTOV), an innovative biopharmaceutical company, announced ... at 8:30am Eastern Time to discuss the recent acquisition of a majority ...
(Date:1/17/2017)... DUBLIN , Jan. 17, 2017  Jazz Pharmaceuticals ... first patient has been enrolled in a Phase 3 ... versus best supportive care (BSC) in the prevention of ... undergoing hematopoietic stem cell transplant (HSCT) who are at ... VOD.  The defibrotide clinical trial will be conducted across ...
Breaking Medicine Technology: